As of January 7, 2020, twenty-three clinical trials had been authorized to evaluate the efficacy of hydroxychloroquine as a treatment against coronavirus in Spain. The antivirus drug Remdesivir from the pharmaceutical company Gilead ranked third with a total of nine clinical trials in the country. This medicine has been the first to obtain a conditional authorization from the European Medicines Agency and the American Food and Drug Administration for use in patients with COVID-19.
Number of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by active ingredient
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
AEMPS. (January 7, 2021). Number of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by active ingredient [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1167854/covid-19-essays-clinicians-authorized-in-spain-by-beginning-active/
AEMPS. "Number of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by active ingredient." Chart. January 7, 2021. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1167854/covid-19-essays-clinicians-authorized-in-spain-by-beginning-active/
AEMPS. (2021). Number of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by active ingredient. Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1167854/covid-19-essays-clinicians-authorized-in-spain-by-beginning-active/
AEMPS. "Number of Clinical Trials of Coronavirus Treatments Authorized in Spain as of January 2021, by Active Ingredient." Statista, Statista Inc., 7 Jan 2021, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1167854/covid-19-essays-clinicians-authorized-in-spain-by-beginning-active/
AEMPS, Number of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by active ingredient Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1167854/covid-19-essays-clinicians-authorized-in-spain-by-beginning-active/ (last visited November 13, 2024)
Number of clinical trials of coronavirus treatments authorized in Spain as of January 2021, by active ingredient [Graph], AEMPS, January 7, 2021. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1167854/covid-19-essays-clinicians-authorized-in-spain-by-beginning-active/
